Treatment of Infected Hip Arthroplasty by Hernigou, Philippe et al.
126  The Open Orthopaedics Journal, 2010, 4, 126-131   
 
  1874-3250/10  2010 Bentham Open 
Open Access 
Treatment of Infected Hip Arthroplasty 
Philippe Hernigou
*,1,2, C.-H. Flouzat-Lachianette
2, R. Jalil
2, Sobrinho Uirassu Batista
3, I. Guissou
2 
and A. Poignard
2 
1University Paris XII, 
2Hôpital Henri Mondor, 94010 Creteil, France 
3Hospital Edgar Santos, University Federal of Bahia, Salvador, Brazil 
Abstract: The clinical outcomes of a consecutive series of deep total joint infections treated with a prosthesis retaining 
protocol were reviewed. The treatment of deep periprosthetic joint infections is challenging. In recent years, two-stage 
exchange arthroplasty has emerged as the gold standard for successful elimination of infection. With success rates 
averaging 82% to 96%, this treatment method has both the highest and most consistent rate of infection eradication. 
Another alternative in the treatment of the deep periprosthetic infection is the single-stage exchange arthroplasty. 
Successful eradication of infection after single-stage exchange arthroplasty has been reported to average from 60% to 83% 
after total hip infections. While both the single and two-stage exchange arthroplasty are viable treatment options, they are 
associated with negative factors such as they are time consuming, expensive, and may entail a 6- to 12-week period with a 
minimally functioning extremity after prosthesis removal. This paper reports the general principles of management, the 
treatment of acute infection occurring in the postoperative period or later, and the treatment of chronic infection by 
exchange arthroplasty or resection arthroplasty. 
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1. INTRODUCTION 
  The most effective treatment for an infected total hip 
replacement (THR) is controversial [1]. Many questions 
remain. For example, in patients with chronic infection 
requiring exchange arthroplasty, should the procedure be 
done in one or two stages? In acute infection, should the 
prosthesis be exchanged, or is soft-tissue debridement 
sufficient? Does resection arthroplasty provide better control 
of infection than exchange arthroplasty? In exchange 
arthroplasty, can cementless prostheses be used, or is 
antibioticloaded bone cement required? With the use of 
modern sterile surgical technique, unidirectional airflow 
systems, and preoperative antibiotics, the infection rate in 
total joint replacement has fallen to approximately 1% to 
2.5%.
 Although this percentage is small, the annual number 
of primary arthroplasty procedures continues to grow 
dramatically due to an aging population. In order to limit 
patient morbidity and minimize the economic impact of 
infected revision arthroplasty, continued efforts should be 
directed to improve the treatments for deep periprosthetic 
infections. 
  We will discuss the general principles of management, 
the treatment of acute infection occurring in the 
postoperative period or later, and the treatment of chronic 
infection by exchange arthroplasty or resection arthroplasty. 
  Periprosthetic infection is a debilitating and costly 
complication of total joint arthroplasty. 
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2. GENERAL PRINCIPLES OF MANAGEMENT 
  The management strategy depends on whether the 
infection is confined to the soft tissues or extends to the 
bone. Selection of the best strategy requires evaluation by a 
multidisciplinary team which includes specialists in 
infectious disease but is co-ordinated by orthopaedic 
surgeons. 
2.1. Nature of the Infected Tissues 
  The mechanism of the infection, whether by 
intraoperative contamination or delayed 'haematogenous' 
infection, has no bearing on the selection of treatment. 
Indeed, different mechanisms of infection lead to similar 
lesions. Both the acute infection which develops within a 
few days after intraoperative contamination and the delayed 
haematogenous contamination are initially confined to the 
soft tissues, so that there is no need to change the prosthesis 
or debride the bone [2-4]. Conversely, chronic infection 
involves both the soft tissues and bone. Under these 
circumstances, the bone must be debrided and the prosthesis 
changed irrespective of whether the patient has septic 
loosening diagnosed long after intraoperative contamination 
or delayed 'haematogenous' contamination with the gradual 
development of chronic osteitis despite systemic antibiotic 
therapy [5-7]. 
2.2. Mechanism of Infection 
  Four main mechanisms may lead to infection of a THR. 
2.2.1. Intraoperative Contamination 
  This was formerly the most common mechanism, but the 
widespread use of prophylactic antibiotics have altered this.  
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Intraoperative contamination is responsible for only a few 
cases of infection of orthopedic implants. The infection 
which follows intraoperative contamination has two clinical 
patterns. The first is acute postoperative infection. This is 
now exceedingly rare. The diagnosis is readily made on the 
basis of inflammation of the wound with fever. During the 
first few days, the infection is confined to the soft tissues, 
with no osteitis. The second is gradual septic loosening 
which is the most common presentation. Poor function after 
arthroplasty with loss of function over time is characteristic. 
Osteitis is consistently present. 
2.2.2. Delayed Contamination 
  This is now a common mechanism. The prosthesis, 
which is sterile initially, is contaminated from bacterial 
sources located elsewhere in the body, usually via  the 
bloodstream but occasionally via  the Iymphatics. 
Microbiological studies will identify the same organism in 
the remote focus and the hip, thus providing the mechanism 
of infection. 
  Delayed contamination after several years of satisfactory 
function is the most common pattern, and also the most 
typical. Pain in the hip and fever develop in a patient who 
has an active focus of infection, often in the skin, teeth, lungs 
or urinary tract. The risk of colonisation of the prosthesis is 
greatly increased by local inflammation of the hip, which 
may be due to synovitis in response to wear particles from 
the prosthesis. According to the geographic area (US versus 
Europe), there is difference on prophylaxis for dental 
procedures (US does and UK doesn’t). 
  Haematogenous contamination can occur in the 
immediate postoperative period from a pulmonary, urinary 
tract, or catheter-related infection. The clinical pattern is 
similar to that of infection secondary to intraoperative 
contamination. However, the presence of the primary focus 
of infection and the identity of the pathogen at the two sites 
establishes the diagnosis of 'haematogenous' infection. 
2.2.3. Contamination by Direct Spread 
  Although this mechanism occurs mainly at the knee in 
patients with delayed skin healing, it can occur at the hip, 
particularly in association with reoperation for a periprosthetic 
fracture. 
2.2.4. Infections Related to Reactivation of an Indolent 
Infection 
  These occur mainly in patients with a pre-THR history of 
hip surgery, such as femoral osteotomy or treatment of an 
acetabular fracture. The infection goes unrecognised until it 
is reactivated by implantation of the prosthesis. 
2.3. Nature of the Infected Tissues 
  This is the main consideration. Acute infection is confined 
to the soft tissues, at least during the first week. This is the 
case in delayed contamination in which the infection initially 
involves the tissues surrounding the prosthetic joint [8-10]. 
Another example is acute intraoperative contamination in 
which soft-tissue infection initially occurs without infection or 
necrosis of the bone. In acute infection, urgent surgery is 
needed to remove the infected soft tissues. The bone and 
prosthesis are left untouched. 
  There are exceptions to this rule, however, because some 
organisms produce slime, which deposits on the implant. 
Within 24 hours, the slime coating the prosthesis limits the 
effectiveness of antibiotic therapy, and surgical debridement 
of the prosthesis is not always aufficient to ensure 
decontamination. 
  Chronic infection extends into the bone. Surgical 
treatment is essential in this situation regardless of the 
mechanism of the infection, either intraoperative 
contamination manifesting secondarily as septic loosening or 
delayed contamination with the gradual development of 
infectious osteolysis. These lesions require removal of the 
infected prosthesis, excision of the necrotic bone and 
implantation of a new prosthesis. 
  Contamination by direct spread usually results in acute 
soft-tissue infection when diagnosed early, whereas 
reactivation of chronic infection typically manifests as 
chronic infection with osteitis. 
2.4. Management should be Multidisciplinary 
  The goal of management is not only to eradicate the 
infection but also to preserve the function of the hip by 
protecting both bone stock and muscle function. 
  Help should be obtained from specialists in infectious 
diseases, particularly to ensure that the most appropriate 
systemic antibiotics are used. Resolution of the infection can 
be achieved without systemic antibiotics, as reported initially 
by Buchholz et al. [3], who obtained a cure rate of 77% in 
583  revisions, but only at the cost of extensive bone and 
soft-tissue resection which compromises long-term function. 
Long-term palliative antibiotic therapy, however, can be 
used in patients whose poor general health poses 
unacceptable operative risks, but it merely alleviates the 
symptoms without eradicating the infection. 
  With systemic antibiotics, tissue which is infected but not 
necrotic can be left in place. This tissue has a blood supply 
and, consequently, can be sterilised by systemic antibiotics. 
Necrotic tissue, however, perpetuates the infection and 
therefore must be removed surgically. Prosthetic components 
which are colonised by slime should also be removed. The 
production of slime can be assessed on culture of aspirated 
fluid. However some autors have reported good results 
without prolonged course of antibiotic therapy. Stockley [11] 
reported a series of 114 patients with microbiologically-
proven chronically-infected total hip replacement, treated 
between 1991 and 2004 by a two-stage exchange procedure 
with antibiotic-loaded cement, but without the use of a 
prolonged course of antibiotic therapy. The mean follow-up 
for all patients was 74 months (2 to 175) with all surviving 
patients having a minimum follow-up of two years. Infection 
was successfully eradicated in 100 patients (87.7%), a rate 
which is similar to that reported by others, but where 
prolonged adjuvant antibiotic therapy has been used. Using 
the technique described, a prolonged course of systemic 
antibiotics does not appear to be essential and the high cost 
of the administration of antibiotics can be avoided. 
  Specialists in infectious diseases who contribute to the 
management of patients with an infected arthroplasty should 
be aware that systemic antibiotics have only limited access 
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supply because of implantation of the prosthesis. Adjuvant local 
treatment with antibiotics may be used under these conditions. 
  The orthopaedic surgeon should be in charge of 
co-ordinating the treatment because the objective is not only to 
eliminate the infection but also to ensure functional recovery. 
For instance, treatment which is somewhat less effective in 
terms of control of infection may have a lower rate of 
mechanical complications and ultimately lead to better function. 
Satisfactory function is paramount to the patients who are not 
enthusiastic about full recovery from the infection at the 
expense of loss of function. 
  Patients with infections of moderate severity will benefit 
more from 'adapted' surgery than from aggressive surgery. The 
latter involves a two-stage procedure or femorotomy and 
ensures control of the infection in most of patients, but with 
mechanical complications in about 25%. Only about 75% of 
patients have a good functional result. 
  'Adapted' surgery (one-stage procedure, endofemoral 
technique) may control the infection in a less number of 
patients, but as mechanical complications occur in only 10%, 
about the same number of patients have a good functional result. 
In addition to this functional benefit, the treatment is shorter, 
less demanding to the patient, and less costly. 
  Thus, the orthopaedic surgeon must tailor the strategy to the 
needs of each patient. Adjuvant local antibiotic therapy should 
be used whenever this is likely to reduce the extent of the 
surgical procedure. 
3. ACUTE INFECTION TREATED WITH 
DEBRIDEMENT 
  The original incision is reopened, the prosthesis is dislocated 
to facilitate excision of infected soft tissue, and the extraosseous 
parts of the prosthesis is cleaned but left in place [12-14]. It can 
be strongly recommended within the first three weeks 
afterarthroplasty. Furthermore, the rate of recovery seen with 
this minor procedure between three and six weeks after THR is 
valuable, particularly in frail patients. By contrast, synovectomy 
is rarely effective beyond the sixth week, and radiological 
evidence of osteitis is associated with an extremely high rate of 
failure. 
  Every effort should be made to prevent acute infections. 
Prophylactic antibiotics should be given. Antibiotic-loaded bone 
cement seems to protect against 'haematogenous' infection for at 
least six months. Indolent foci of infection (teeth, sinuses) 
should be eliminated before arthroplasty. Venous catheters 
should be removed early. 
4. RESECTION ARTHROPLASTY IN CHRONIC 
INFECTION 
  Most patients have radiological evidence of both endosteal 
osteolysis and a femoral periosteal reaction. The osteolysis 
usually affects both the stem and the cup. Aspiration of the hip 
confirms the diagnosis and identifies the pathogen. Factors of 
adverse prognostic significance must be sought before deciding 
on whether to perform exchange or resection arthroplasty [15]. 
4.1. Factors of Adverse Prognostic Significance 
  At least three factors are of adverse prognostic 
significance. 
4.1.1. The Nature of the Organism 
  Gram-negative organisms, polymicrobial infection, and 
failure to identify an organism despite histological evidence 
of infection may be associated with a poor outcome. 
Coagulase-negative staphylococci are often less susceptible 
to antibiotics than Staphylococcus aureus. 
Methicillin-resistant  Staph. aureus (MRSA) is a dreaded 
organism, mainly because of the precautions required to 
prevent its dissemination, rather than because of its 
resistance to antibiotics. 
4.1.2. Local Factors 
  These particularly include the presence of a draining 
sinus, soft-tissue scarring related to multiple surgical 
procedures, factors associated with a high risk of 
complications during removal of the prosthesis such as a 
wellfixed fully-coated stem and well-fixed cement, or 
extensive osteolysis requiring reconstruction of bone stock 
by allografting. 
4.1.3. General Health Status 
  This includes the ASA score, the psychological status, 
the need for chronic anticoagulant therapy, etc. 
4.2. Resection Arthroplasty 
  Resection arthroplasty is associated with poor function 
and does not seem to decrease the risk of death as compared 
with exchange arthroplasty. Control of infection is no better 
than with exchange arthroplasty. For these reasons, resection 
arthroplasty should be reserved for patients whose medical 
condition is poor (ASA 3 or 4) and have a history of failed 
prosthesis-sparing surgery. 
5. EXCHANGE ARTHROPLASTY IN CHRONIC 
INFECTION 
  Exchange arthroplasty raises several important questions 
[16-29]. In terms of the control of infection is there a 
difference between direct exchange and two-stage exchange 
or between cementless prostheses and prostheses secured 
with antibiotic-loaded bone? Do direct exchange and two-
stage exchange provide similar functional results? Do 
techniques such as femorotomy or the use of a spacer 
improve the results? 
5.1. Control of Infection 
5.1.1. Systemic Antibiotic Therapy 
  There is evidence that acceptable rates of control of 
infection can be achieved without systemic antibiotics:77% 
in a series of 583 exchange arthroplasties with antibiotic-
loaded bone cement alone [3]. However, systemic antibiotic 
therapy is now used routinely because it increases further the 
control rate of infection. It is, however, only one of the 
factors leading to control. 
  Data from different series indicate that the optimal 
duration of systemic antibiotic treatment is three to four 
months. Therefore, when two-stage exchange is performed, 
the interval between the two stages should be between 45 
days and three months. This delay requires the use of an 
appropriate spacer. Systemic antibiotics should not be given 
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  Starting systemic antibiotics before the excision 
procedure does not improve the rate of control of infection 
and can interfere with the interpretation of intraoperative 
bacteriological specimens. 
5.1.2. Antibiotic-Loaded Bone Cement or Cementless 
Prosthesis? 
  The difference of results is not statistically significant in 
the litterature. Again, this insignificant difference does not 
mean that using antibiotic-loaded bone cement to secure the 
final prosthesis had no effect. The decision to use antibiotic-
loaded bone cement was often based on the severity of the 
infection. patients who did not receive a prosthesis secured 
with antibiotic-loaded bone cement had usually no MRSA, 
as compared with patients treated with antibiotic-loaded 
bone cement. Treatment without antibiotic-loaded bone 
cement to secure the prosthesis provided high cure rates in 
patients with moderate infection, but adding antibiotic-
loaded bone cement produced higher cure rates in severe 
infections. 
5.2. Functional Results 
  These were evaluated on the basis of perioperative 
complications, function and survival of the prosthesis. There 
has been concern that the multiple procedures needed for 
two-stage exchange may be associated with a higher rate of 
intraoperative fractures, damage to soft tissues, particularly 
the gluteal muscles with dislocations, and compromise of the 
blood supply to the bone with an increased risk of non-septic 
loosening in the medium and long term. 
  The rate of mechanical complications is two to three 
times higher with two-stage exchange than with direct 
exchange. In two-stage exchange, the first and second 
procedures are associated with similar rates of fracture and 
perforation, so that the final rates were doubled as compared 
with those of direct exchange. Dislocation is increased in 
patients with two-stage exchange. 
  Survival of the prosthesis should also be evaluated 
carefully. There are marked differences in complication rates 
and prosthesis survival. Complications occur in fewer than 
10% of patients with direct exchange, which is less than half 
the rate seen with two-stage exchange. The slightly better 
rates of control of infection with two-stage exchange are 
obtained only at the expense of much less satisfactory 
functional results. It follows that two-stage exchange should 
be used only when the infection is so severe as to leave no 
other option. 
5.3. Influence of Surgical Techniques 
5.3.1. Femorotomy 
  The femur is opened like a book by cutting an 
anterolateral flap with a pedicle of vastus lateralis. The flap 
is used to remove material which cannot be extracted via the 
proximal route such as a fully-coated stem or distal 
well-fixed cement. Furthermore, the flap allows thorough 
cleansing of the infected tissue. Femorotomy is useful in   
decreasing the rate of complications during removal of the 
prosthesis, particularly in patients with cementless 
prostheses. 
 
5.3.2. Spacer 
  The use of a spacer allowed a delay of several months 
between the two stages, a distinct advantage since control of 
infection may sometimes need several months of 
postoperative antibiotic therapy [30-42]. The use of a spacer 
should furfil several criteria as follows: 
-  The spacer should contain antibiotic-loaded cement, 
in particular to cancel out the foreign-body effect in a 
minimally infected environment. 
-  Stability should be aufficient to avoid shortening of 
the limb and to allow early mobilisation and walking 
for at least three months, since this is a possivble 
interval between stages. 
-  Removal should be easy, with no fracturing or 
migration during the second procedure. 
  The disadvantages of spacers which are composed only of 
methacrylate include insufficient stability with mobility in the 
femoral shaft or, on the contrary, cancellous penetration making 
removal difficult, and friction of the methacrylate on the raw 
acetabular bone, which may cause pain and shedding of 
methacrylate particles which inhibit physiological defence 
mechanisms against infection. Some surgeons prefer to use a 
'prosthesis-spacer'. Its shape ensures stability. The antibiotic-
loaded cement is separated from the bone by a thin layer (< 0.5 
mm) of resorbable cellulose Surgicel. This is aufficient to 
ensure stability allowing weight-bearing without pain and easy 
removal of the cement which does not penetrate the cancellous 
bone. In addition, the metal-polyethylene prosthesis facilitates 
rehabilitation and prevents abrasion of the cement. 
5.4. Direct or Two-Stage Exchange? 
  In specialised departments in which tissue excision is 
performed according to stringent rules and the surgeons 
work in collaboration with specialists in infectious diseases 
the rate of control of infection is 85%, with a variety of 
techniques. When necessary, control of infection and 
functional results should be weighed against each other, 
bearing in mind that the more aggressive surgical techniques 
for combating infection may increase the risk of functional 
complications in the perioperative period and subsequent 
aseptic loosening. 
  Thus, treatment should be tailored to the severity of the 
infection. 
  In patients with moderate infection, direct exchange with 
antibiotic-loaded bone cement and two-stage exchange 
without antibiotic-loaded bone cement provide similar 
results. However, preference should be given to direct 
exchange, since the functional results are clearly better. In 
patients with very severe infection, all available therapeutic 
weapons, both two-stage exchange and antibiotic-loaded 
bone cement, should be used. 
  These considerations allow the following strategy for the 
patients: 
5.4.1. Moderate Infection  
  Either of the following treatments can be used: a) direct 
exchange with antibiotic-loaded bone cement, particularly   
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when the prosthesis can be removed without a femoral flap, 
or b) direct exchange with a cementless prosthesis, either as 
the first choice, or as the best mechanical possibility when a 
femoral flap is needed. Long hydroxyapatite-coated stems 
are more stable in this situation than cemented prostheses 
anchored only at their distal end. 
5.4.2. Severe Infection 
  As a rule, direct exchange with antibiotic-loaded bone 
cement should be used. two-stage exchange is advocated 
only if a need for a femoral flap or a cortical allograft arises 
during the procedure. 
5.4.3. Very Severe Infection (Multiple Resistance or 
Unidentified Organisms, Failure of Well-Conducted Direct 
Exchange) 
  In this instance, two-stage exchange should be used and a 
spacer with antibioticloaded cement used between the 
procedures. Although a cementless prosthesis can be used 
for the final procedure, we believe that a prosthesis with 
antibiotic-loaded bone cement is preferable whenever 
satisfactory metaphyseal mechanical fixation can be 
achieved. 
  The general health status of the patient should also be 
considered. We recommend direct exchange in elderly or 
severely debilitated patients, in whom the slightly lower rate 
of controll of infection is more than compensated for by the 
reduced incidence of mechanical complications, which are 
poorly tolerated by older patients. 
6. CONCLUSIONS 
  Specialised multidisciplinary care produces encouraging 
results in revision surgery for an infected arthroplasty. The 
rate of control of infection is about 85% in patients with 
acute infection treated within the first three weeks, or with 
chronic infection treated with direct exchange or two-stage 
exchange. 
  In acute postoperative infections, further surgery with 
excision of infected soft tissues and cleaning of the 
prosthesis produces good results in 80% of patients within 
the first three weeks. 
  In acute infections related to secondary contamination of 
the prosthesis after several years of normal function, the 
same procedure should be performed in patients seen within 
three weeks of the onset of the infection. This minor 
procedure ensures recovery in one-third of patients if they 
have no radiological evidence of loosening or osteitis. After 
six to 12 weeks, the infection involves the bone and requires 
exchange or resection arthroplasty. 
  Simple resection arthroplasty (Girdles/one's procedure) 
does not increase the rate of control of infection (84%) as 
compared with exchange arthroplasty and produces 
devastating functional loss. This technique should be 
reserved for patients whose poor general health precludes 
function-salvaging procedures. 
  Exchange arthroplasty, whether direct or in two stages, is 
effective in controlling the infection, with more than 85% of 
patients having a good result. It is, however, associated with 
mechanical complications which require further surgery in a 
number of cases (10% with direct exchange and 20% with 
two-stage exchange). 
  Studies of series of THR revisions in patients with 
moderate or severe infection show that similar rates of 
control of infection have been achieved with the various 
treatment strategies. The explanation for this similarity in 
results is that the least aggressive treatments involving direct 
exchange and cementless prostheses, have been used in 
moderate infections and the more aggressive treatments 
involving two-stage exchange and antibiotic-loaded bone 
cement in complex cases. Data in the literature indicate that, 
as compared with direct exchange without antibiotic-loaded 
bone cement, either two-stage exchange or the use of 
antibiotic-loaded bone cement produces a similar 
improvement in control of infection. The rate of mechanical 
complications, however, is noticeably higher with two-stage 
exchange. 
  Consequently, the least aggressive surgical techniques 
should be used in patients with moderate infection (direct 
exchange, possibly with a cementless prosthesis). Direct 
exchange with antibiotic-loaded bone cement is indicated in 
patients with severe infection and/or with poor general health 
making repeated surgery undesirable. two-stage exchange 
with an antibiotic-loaded spacer prosthesis is the best choice 
in patients with very severe infections. 
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